← Back to Search

Mobile Health Strategy for Premature Birth

N/A
Waitlist Available
Led By Jason Wang, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women 16-50 years of age
Women who can read, write and understand English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Study Summary

This trial will compare a mobile health strategy to a traditional paper-based health strategy to see if it can reduce the number of spontaneous preterm births.

Who is the study for?
This trial is for women aged 16-50 who have had a preterm infant and own a mobile phone. They must be able to read and understand English, with their child previously in neonatal care due to premature birth. Women without prior preterm births or those without a mobile phone are excluded.Check my eligibility
What is being tested?
The study tests the PretermConnect App's effectiveness in reducing recurrent preterm births by enhancing patient engagement, care coordination, and adherence to recommended practices compared to traditional paper-based methods.See study design
What are the potential side effects?
Since this trial involves the use of an app rather than medication, there are no direct medical side effects. However, participants may experience increased screen time which could affect sleep patterns or eye strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 16 and 50.
Select...
I can read, write, and understand English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interpregnancy interval
Secondary outcome measures
Breastmilk feeding
Mother-infant bonding
Postpartum depression

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PretermConnect AppExperimental Treatment1 Intervention
Participants will receive health education via a mobile app, PretermConnect
Group II: ControlActive Control1 Intervention
Participants will receive paper-based health education as part of standard of care

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,342,951 Total Patients Enrolled
11 Trials studying Premature Birth
2,879 Patients Enrolled for Premature Birth
University of Pittsburgh Medical CenterOTHER
70 Previous Clinical Trials
75,994 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
710 Previous Clinical Trials
8,588,708 Total Patients Enrolled
12 Trials studying Premature Birth
3,943 Patients Enrolled for Premature Birth

Media Library

Use of PretermConnect App Clinical Trial Eligibility Overview. Trial Name: NCT04663607 — N/A
Premature Birth Research Study Groups: Control, PretermConnect App
Premature Birth Clinical Trial 2023: Use of PretermConnect App Highlights & Side Effects. Trial Name: NCT04663607 — N/A
Use of PretermConnect App 2023 Treatment Timeline for Medical Study. Trial Name: NCT04663607 — N/A
~22 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top